Two foundational factors, sleep and stress, deserve special attention in the context of semaglutide treatment
Baessler A, Hasinoff MJ, Fischer M, Reinhard W, Sonnenberg GE, Olivier M, et al
Consumers may benefit from reviewing the FDA's current public guidance on compounded GLP-1 products before making treatment decisions
For now, the anecdotal evidence is a source of hope for women with endometriosis exploring their treatment options
Additionally, patients with heart failure especially those with reduced ejection fraction should be monitored closely for increases in heart rate when starting GLP-1 therapies
demonstrated that curcumin dose-dependently alleviated pain-depression behaviors